Evolving use and indications for implantable cardioverter defibrillators.
作者信息
de Groot J R
机构信息
Department of Cardiology, Amsterdam University Medical Centers/University of Amsterdam, Heart Center, Amsterdam, The Netherlands.
出版信息
Neth Heart J. 2018 Dec;26(12):581-583. doi: 10.1007/s12471-018-1193-2.
Abstract
摘要
相似文献
1
Evolving use and indications for implantable cardioverter defibrillators.
Neth Heart J. 2018 Dec;26(12):581-583. doi: 10.1007/s12471-018-1193-2.
2
Implantable cardioverter-defibrillator: present and future indications.
Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:141-7.
3
Implantable cardioverter-defibrillator advances.
Curr Opin Cardiol. 1996 Jan;11(1):16-22. doi: 10.1097/00001573-199601000-00004.
4
Implantable cardioverter-defibrillators: expanding indications.
Curr Opin Cardiol. 2004 Jul;19(4):317-22. doi: 10.1097/01.hco.0000129666.57492.45.
5
Organisation of care for Swedish patients with an implantable cardioverter defibrillator, a national survey.
J Clin Nurs. 2011 Sep;20(17-18):2600-8. doi: 10.1111/j.1365-2702.2010.03540.x. Epub 2010 Oct 21.
6
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
J Am Heart Assoc. 2017 Nov 9;6(11):e006937. doi: 10.1161/JAHA.117.006937.
7
Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.
8
Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
J Hosp Palliat Nurs. 2018 Feb;20(1):63-71. doi: 10.1097/NJH.0000000000000399.
9
Dual-chamber implantable cardioverter-defibrillators for nonpacing indications: comment on "variation in use of dual-chamber implantable cardioverter defibrillators".
Arch Intern Med. 2012 Apr 23;172(8):641. doi: 10.1001/archinternmed.2012.710.
10
Quality of life and psychological status of patients with implantable cardioverter defibrillators.
Am J Crit Care. 2006 Jul;15(4):389-98.
本文引用的文献
1
Influence of permanent pacemaker implantation after transcatheter aortic valve implantation with new-generation devices.
Neth Heart J. 2018 Dec;26(12):620-627. doi: 10.1007/s12471-018-1194-1.
2
Magnetic resonance imaging in patients with cardiac implantable electronic devices.
Neth Heart J. 2018 Dec;26(12):584-590. doi: 10.1007/s12471-018-1192-3.
3
Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients.
Neth Heart J. 2018 Dec;26(12):612-619. doi: 10.1007/s12471-018-1186-1.
4
Silent atrial fibrillation in patients with an implantable cardioverter defibrillator and coronary artery disease (INDICO AF) trial: study rationale and design.
Neth Heart J. 2018 Dec;26(12):628-633. doi: 10.1007/s12471-018-1185-2.
5
Device updates successfully reduce T‑wave oversensing and inappropriate shocks in subcutaneous ICD patients.
Neth Heart J. 2018 Dec;26(12):606-611. doi: 10.1007/s12471-018-1160-y.
6
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
Am Heart J. 2017 Aug;190:12-18. doi: 10.1016/j.ahj.2017.04.015. Epub 2017 May 3.
7
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.
Am Heart J. 2017 Jul;189:137-145. doi: 10.1016/j.ahj.2017.04.008. Epub 2017 Apr 24.
8
Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.
Heart Rhythm. 2014 Mar;11(3):426-34. doi: 10.1016/j.hrthm.2013.12.007. Epub 2013 Dec 7.
9
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.
10
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
N Engl J Med. 1997 Nov 27;337(22):1576-83. doi: 10.1056/NEJM199711273372202.
Zotero 插件